|
6567735b212eaade2e0e1296
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022099
|
76_60661
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.86272
|
0
|
0
|
0
|
0.86272
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735b212eaade2e0e1297
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019020776B
|
76_58926
|
1
|
Ukraine
|
Europe
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.5
|
1.95522
|
0
|
0
|
1.5
|
1.95522
|
0
|
1.5
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
SAFE, AFFORDABLE, AND EFFECTIV...E MEDICINES FOR UKRAINIANS (SAFEMED)
more
|
Safe, Affordable, and Effectiv...e Medicines for Ukrainians (SAFEMed)
more
|
SAFEMed will lead anti-corrupt...ion interventions in the pharmaceutical sector by building the country's capacity for transparent procurement of drugs and commodities and a sustainable national medicines selection process. The project will develop a procurement strategy to facilitate establishment of an efficient and cost-effective Central Procurement Body and will support adoption of evidence-based pharmaceutical laws, policies, regulations, and guidelines to address policy and legislative barriers. SAFEMed will support the Ministry of Health in the creation of the health technology assessment (HTA) agency as a legal entity for selection of effective and cost-effective medicines for procurement and reimbursement and will adopt and institutionalize best HTA practices. SAFEMed will also contribute to the creation of sustainable health pharmaceutical financing and advance rational pharmaceutical management and the supply chain system. The solutions will support decentralization and integration of health services across national and sub-national levels and secure a stable supply of essential HIV, medication-assisted treatment (MAT), TB, and Hepatitis C virus (HCV) drugs and commodities at their best prices in order to improve access to medicines and health services.
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735b212eaade2e0e1298
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009872B
|
76_42198
|
3
|
Uzbekistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.306856
|
0
|
0
|
0
|
0.306856
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735b212eaade2e0e1299
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009872A
|
76_42198
|
3
|
Uzbekistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.081691
|
0
|
0
|
0
|
0.081691
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735b212eaade2e0e129a
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024007
|
76_62926
|
1
|
Uzbekistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.85
|
0
|
0
|
0
|
0.85
|
0
|
0
|
|
|
0.85
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735b212eaade2e0e129b
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009859
|
76_42198
|
3
|
West Bank and Gaza Strip
|
Middle East
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.247044
|
0
|
0
|
0
|
0.247044
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735b212eaade2e0e129c
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021654B
|
76_63583
|
1
|
Asia, regional
|
Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.329938
|
0.047294
|
0
|
0
|
0.329938
|
0.047294
|
0
|
0.329938
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735c212eaade2e0e129d
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021654A
|
76_63583
|
1
|
Asia, regional
|
Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.100584
|
0.003254
|
0
|
0
|
0.100584
|
0.003254
|
0
|
0.100584
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735c212eaade2e0e129e
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019744G
|
76_61158
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.1
|
0.1
|
0
|
0
|
0.1
|
0.1
|
0
|
|
|
0.1
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735c212eaade2e0e129f
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019744B
|
76_61158
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.65
|
0
|
0
|
0
|
0.65
|
0
|
0
|
0.65
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735c212eaade2e0e12a0
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021636D
|
76_63583
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.4
|
0.28259
|
0
|
0
|
0.4
|
0.28259
|
0
|
0.4
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12110
|
Health policy and administrati...ve management
more
|
|
I.2.a. Health, General
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735c212eaade2e0e12a1
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021636C
|
76_63583
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.1
|
0
|
0
|
0
|
0.1
|
0
|
0
|
0.1
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735c212eaade2e0e12a2
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021636F
|
76_63583
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.25
|
0.237258
|
0
|
0
|
0.25
|
0.237258
|
0
|
0.25
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735c212eaade2e0e12a3
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021636E
|
76_63583
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0.2
|
0
|
0
|
0.2
|
0.2
|
0
|
0.2
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12264
|
COVID-19 control
|
COVID-19
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735c212eaade2e0e12a4
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021636B
|
76_63583
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.1
|
0.080714
|
0
|
0
|
0.1
|
0.080714
|
0
|
0.1
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735c212eaade2e0e12a5
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021636A
|
76_63583
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.1
|
0
|
0
|
0
|
0.1
|
0
|
0
|
0.1
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735c212eaade2e0e12a6
|
2020
|
Germany
|
Foreign Office
|
2020008689
|
6614727
|
1
|
Central African Republic
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.356945
|
0.2032745
|
0
|
0
|
0.71389
|
0.406549
|
|
0.71389
|
|
0
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
50
|
LIFE-SAVING PROTEXTIVE MEASURE...S IN CENTRAL AFRICAN REPUBLIK
more
|
Life-saving protextive measure...s in Central African Republik
more
|
Life-saving protective measure...s and health care for people in need in Zémio, Central African Republic.
more
|
|
72010
|
Material relief assistance and... services
more
|
|
VIII.1. Emergency Response
|
21000
|
International NGO
|
International Rescue Committee... (IRC)
more
|
|
|
|
6567735d212eaade2e0e12a7
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021639
|
76_63583
|
1
|
Benin
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.15
|
0.002238
|
0
|
0
|
0.15
|
0.002238
|
0
|
0.15
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735d212eaade2e0e12a8
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008699
|
76_42350
|
1
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.001071
|
0
|
0
|
0
|
0.001071
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735d212eaade2e0e12a9
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019762D
|
76_61158
|
1
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.468278
|
0
|
0
|
0.5
|
0.468278
|
0
|
|
|
0.5
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735d212eaade2e0e12aa
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021651
|
76_63583
|
1
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.235
|
0.00259
|
0
|
0
|
0.235
|
0.00259
|
0
|
0.235
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735d212eaade2e0e12ab
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019745D
|
76_61158
|
1
|
Cameroon
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.415659
|
0
|
0
|
0.5
|
0.415659
|
0
|
|
|
0.5
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735d212eaade2e0e12ac
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021655
|
76_63583
|
1
|
Central Asia, regional
|
South & Central Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.54
|
0.348043
|
0
|
0
|
0.54
|
0.348043
|
0
|
0.54
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735d212eaade2e0e12ad
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019749D
|
76_61158
|
3
|
Côte d'Ivoire
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.748692
|
0
|
0
|
0
|
0.748692
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735d212eaade2e0e12ae
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021638
|
76_63583
|
1
|
Democratic Republic of the Con...go
more
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.319
|
0
|
0
|
0
|
0.319
|
0
|
0
|
0.319
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735d212eaade2e0e12af
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008701B
|
76_42350
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.056195
|
0
|
0
|
0
|
0.056195
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735d212eaade2e0e12b0
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008701C
|
76_42350
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.093992
|
0
|
0
|
0
|
0.093992
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735d212eaade2e0e12b1
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008701A
|
76_42350
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.131528
|
0
|
0
|
0
|
0.131528
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735e212eaade2e0e12b2
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019763D
|
76_61158
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.175
|
0.079365
|
0
|
0
|
0.175
|
0.079365
|
0
|
|
|
0.175
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735e212eaade2e0e12b3
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021653C
|
76_63583
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.9
|
0.087453
|
0
|
0
|
0.9
|
0.087453
|
0
|
0.9
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735e212eaade2e0e12b4
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021653D
|
76_63583
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.105
|
0.043554
|
0
|
0
|
0.105
|
0.043554
|
0
|
0.105
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735e212eaade2e0e12b5
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021653G
|
76_63583
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.02
|
0.001745
|
0
|
0
|
0.02
|
0.001745
|
0
|
0.02
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735e212eaade2e0e12b6
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021653E
|
76_63583
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.75
|
0.365242
|
0
|
0
|
0.75
|
0.365242
|
0
|
0.75
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735e212eaade2e0e12b7
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021653B
|
76_63583
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.25703
|
0
|
0
|
0.5
|
0.25703
|
0
|
0.5
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735e212eaade2e0e12b8
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021653F
|
76_63583
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.48
|
0.009506
|
0
|
0
|
0.48
|
0.009506
|
0
|
0.48
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735e212eaade2e0e12b9
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021653A
|
76_63583
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.299999
|
0
|
0
|
0
|
0.299999
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735e212eaade2e0e12ba
|
2020
|
Germany
|
Foreign Office
|
2020008702
|
6614763
|
8
|
Brazil
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.128205
|
1.128205
|
0
|
0
|
1.128205
|
1.128205
|
|
1.128205
|
|
0
|
COVID-19
|
COVID-19 General
|
100
|
COVID-19 BASIC HEALTH CARE IN ...BRAZIL
more
|
COVID-19 basic health care in ...Brazil
more
|
Emergency assistance in the ar...eas of basic health care, protection and hygiene to protect indigenous people from COVID-19 in the urban and rural areas of Manaus.
more
|
|
12264
|
COVID-19 control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Donor country-based NGO
|
|
COVID-19
|
|
6567735e212eaade2e0e12bb
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019747E
|
76_61158
|
3
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.949025
|
0
|
0
|
0
|
0.949025
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735f212eaade2e0e12bc
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019747B
|
76_61158
|
1
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.65
|
0
|
0
|
0
|
0.65
|
0
|
0
|
0.65
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735f212eaade2e0e12bd
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021640B
|
76_63583
|
1
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.516118
|
0.174868
|
0
|
0
|
0.516118
|
0.174868
|
0
|
0.516118
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735f212eaade2e0e12be
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021640A
|
76_63583
|
1
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.220602
|
0.04715
|
0
|
0
|
0.220602
|
0.04715
|
0
|
0.220602
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735f212eaade2e0e12bf
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008692
|
76_42350
|
1
|
Ghana
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.001071
|
0
|
0
|
0
|
0.001071
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735f212eaade2e0e12c0
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021641A
|
76_63583
|
1
|
Ghana
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0.003835
|
0
|
0
|
0.2
|
0.003835
|
0
|
0.2
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735f212eaade2e0e12c1
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021641B
|
76_63583
|
1
|
Ghana
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.15
|
0.003627
|
0
|
0
|
0.15
|
0.003627
|
0
|
0.15
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735f212eaade2e0e12c2
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019750B
|
76_61158
|
1
|
Jordan
|
Middle East
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.674701
|
0.418131
|
0
|
0
|
0.674701
|
0.418131
|
0
|
|
|
0.674701
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735f212eaade2e0e12c3
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008694
|
76_42350
|
3
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.122187
|
0
|
0
|
0
|
0.122187
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567735f212eaade2e0e12c4
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019751E
|
76_61158
|
3
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.731293
|
0
|
0
|
0
|
0.731293
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735f212eaade2e0e12c5
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019751B
|
76_61158
|
1
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0
|
0
|
0
|
0.5
|
0
|
0
|
0.5
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677360212eaade2e0e12c6
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021642B
|
76_63583
|
1
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.3
|
0.215519
|
0
|
0
|
0.3
|
0.215519
|
0
|
0.3
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677360212eaade2e0e12c7
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021642A
|
76_63583
|
1
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0.181251
|
0
|
0
|
0.2
|
0.181251
|
0
|
0.2
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
